Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 160

    1.

    Preclinical evaluation of lime juice as a topical microbicide candidate.

    Fletcher PS, Harman SJ, Boothe AR, Doncel GF, Shattock RJ.

    Retrovirology. 2008 Jan 11;5:3.

    PMID:
    18190686
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides.

    Catalone BJ, Kish-Catalone TM, Budgeon LR, Neely EB, Ferguson M, Krebs FC, Howett MK, Labib M, Rando R, Wigdahl B.

    Antimicrob Agents Chemother. 2004 May;48(5):1837-47.

    PMID:
    15105142
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Six-day randomized safety trial of intravaginal lime juice.

    Mauck CK, Ballagh SA, Creinin MD, Weiner DH, Doncel GF, Fichorova RN, Schwartz JL, Chandra N, Callahan MM.

    J Acquir Immune Defic Syndr. 2008 Nov 1;49(3):243-50.

    PMID:
    18845958
    [PubMed - indexed for MEDLINE]
    4.

    Clinical development of microbicides for the prevention of HIV infection.

    D'Cruz OJ, Uckun FM.

    Curr Pharm Des. 2004;10(3):315-36. Review.

    PMID:
    14754390
    [PubMed - indexed for MEDLINE]
    5.

    Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo.

    Trifonova RT, Pasicznyk JM, Fichorova RN.

    Antimicrob Agents Chemother. 2006 Dec;50(12):4005-10. Epub 2006 Oct 9.

    PMID:
    17030562
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Preclinical evaluation of synthetic -2 RANTES as a candidate vaginal microbicide to target CCR5.

    Kish-Catalone TM, Lu W, Gallo RC, DeVico AL.

    Antimicrob Agents Chemother. 2006 Apr;50(4):1497-509.

    PMID:
    16569870
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Assessment of cervicovaginal cytokine levels following exposure to microbicide Nisin gel in rabbits.

    Aranha CC, Gupta SM, Reddy KV.

    Cytokine. 2008 Jul;43(1):63-70. Epub 2008 May 29.

    PMID:
    18513989
    [PubMed - indexed for MEDLINE]
    8.

    Final Report on Carcinogens Background Document for Formaldehyde.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.

    PMID:
    20737003
    [PubMed - as supplied by publisher]
    9.

    A topical microbicide gel formulation of CCR5 antagonist maraviroc prevents HIV-1 vaginal transmission in humanized RAG-hu mice.

    Neff CP, Kurisu T, Ndolo T, Fox K, Akkina R.

    PLoS One. 2011;6(6):e20209. Epub 2011 Jun 1.

    PMID:
    21673796
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    In vitro evaluation of the viability of vaginal cells (VK2/E6E7) and probiotic Lactobacillus species in lemon juice.

    Anukam KC, Reid G.

    Sex Health. 2009 Mar;6(1):67-74.

    PMID:
    19254495
    [PubMed - indexed for MEDLINE]
    11.

    WHI-05, a novel bromo-methoxy substituted phenyl phosphate derivative of zidovudine, is a dual-action spermicide with potent anti-HIV activity.

    D'Cruz OJ, Zhu Z, Yiv SH, Chen CL, Waurzyniak B, Uckun FM.

    Contraception. 1999 May;59(5):319-31.

    PMID:
    10494486
    [PubMed - indexed for MEDLINE]
    12.

    Toxicity, inflammation, and anti-human immunodeficiency virus type 1 activity following exposure to chemical moieties of C31G.

    Catalone BJ, Miller SR, Ferguson ML, Malamud D, Kish-Catalone T, Thakkar NJ, Krebs FC, Howett MK, Wigdahl B.

    Biomed Pharmacother. 2005 Sep;59(8):430-7.

    PMID:
    16154721
    [PubMed - indexed for MEDLINE]
    13.

    The retrocyclin analogue RC-101 prevents human immunodeficiency virus type 1 infection of a model human cervicovaginal tissue construct.

    Cole AL, Herasimtschuk A, Gupta P, Waring AJ, Lehrer RI, Cole AM.

    Immunology. 2007 May;121(1):140-5. Epub 2007 Jan 23.

    PMID:
    17250585
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Lime juice as a candidate microbicide? An open-label safety trial of 10% and 20% lime juice used vaginally.

    Hemmerling A, Potts M, Walsh J, Young-Holt B, Whaley K, Stefanski DA.

    J Womens Health (Larchmt). 2007 Sep;16(7):1041-51.

    PMID:
    17903081
    [PubMed - indexed for MEDLINE]
    15.

    Development of an in vitro dual-chamber model of the female genital tract as a screening tool for epithelial toxicity.

    Gali Y, Ariƫn KK, Praet M, Van den Bergh R, Temmerman M, Delezay O, Vanham G.

    J Virol Methods. 2010 May;165(2):186-97. Epub 2010 Feb 4.

    PMID:
    20138087
    [PubMed - indexed for MEDLINE]
    16.

    Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture.

    Cummins JE Jr, Guarner J, Flowers L, Guenthner PC, Bartlett J, Morken T, Grohskopf LA, Paxton L, Dezzutti CS.

    Antimicrob Agents Chemother. 2007 May;51(5):1770-9. Epub 2007 Mar 12.

    PMID:
    17353237
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    A summary of preclinical topical microbicide vaginal safety and chlamydial efficacy evaluations in a pigtailed macaque model.

    Patton DL, Cosgrove Sweeney YT, Paul KJ.

    Sex Transm Dis. 2008 Oct;35(10):889-97.

    PMID:
    18607310
    [PubMed - indexed for MEDLINE]
    19.

    A 13-week subchronic intravaginal toxicity study of pokeweed antiviral protein in mice.

    D'Cruz OJ, Waurzyniakt B, Uckun FM.

    Phytomedicine. 2004;11(4):342-51.

    PMID:
    15185849
    [PubMed - indexed for MEDLINE]
    20.

    In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide.

    Rohan LC, Moncla BJ, Kunjara Na Ayudhya RP, Cost M, Huang Y, Gai F, Billitto N, Lynam JD, Pryke K, Graebing P, Hopkins N, Rooney JF, Friend D, Dezzutti CS.

    PLoS One. 2010 Feb 19;5(2):e9310.

    PMID:
    20174579
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk